Seven cases of pelvic exenteration combined with sacral resection for locally recurrent rectal cancer
- PMID: 3736057
- DOI: 10.1002/jso.2930320314
Seven cases of pelvic exenteration combined with sacral resection for locally recurrent rectal cancer
Abstract
Local recurrence of rectal cancer following abdominoperineal resection is rarely amenable to limited resection. Carcinoembryonic antigen assay is valuable for diagnosing most recurrent rectal cancers, but it is inadequate for early detection. Pelvic computed tomography examination is very valuable for the early detection and localization of recurrence in relation to pelvic structures and can also serve as a guide in percutaneous needle biopsy of the tumor. Seven patients with deeply invading recurrent lesions underwent pelvic exenteration combined with sacral resection. The ileal segment conduit was used for ureteral urinary diversion. The mean operation time and blood loss were 8.8 hours and 6,200 ml, respectively. No operative deaths were encountered. One patient is alive 22 months postoperatively with no evidence of disease, and another patient is alive 32 months postoperatively with pelvic wall recurrence. This procedure seems a reasonable treatment for palliation and full recovery in certain patients.
Similar articles
-
[Pelvic exenteration combined with sacral resection for recurrent rectal cancer. The roles of carcinoembryonic antigen and pelvic computed tomography for early detection].Nihon Geka Gakkai Zasshi. 1984 Feb;85(2):153-9. Nihon Geka Gakkai Zasshi. 1984. PMID: 6749100 Japanese.
-
Pelvic exenteration combined with sacral resection for recurrent rectal cancer.J Surg Oncol. 1983 Nov;24(3):161-6. doi: 10.1002/jso.2930240302. J Surg Oncol. 1983. PMID: 6632903
-
[Total pelvic exenteration for primary and locally recurrent rectal cancer].Gan No Rinsho. 1984 Nov;30(14):1779-85. Gan No Rinsho. 1984. PMID: 6513031 Japanese.
-
Pelvic exenteration for recurrent rectal cancer.Adv Surg. 1996;29:215-33. Adv Surg. 1996. PMID: 8720005 Review.
-
Surgical management of pelvic malignancy: role of extended abdominoperineal resection/exenteration/abdominal sacral resection.Surg Oncol Clin N Am. 2005 Apr;14(2):197-224. doi: 10.1016/j.soc.2004.12.001. Surg Oncol Clin N Am. 2005. PMID: 15817235 Review. No abstract available.
Cited by
-
Pelvic resection of recurrent rectal cancer.Ann Surg. 1994 Oct;220(4):586-95; discussion 595-7. doi: 10.1097/00000658-199410000-00017. Ann Surg. 1994. PMID: 7524455 Free PMC article.
-
Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer.World J Surg Oncol. 2006 Nov 22;4:83. doi: 10.1186/1477-7819-4-83. World J Surg Oncol. 2006. PMID: 17118210 Free PMC article.
-
Composite resection of posterior pelvic malignancy.Ann Surg. 1992 Jun;215(6):685-93; discussion 693-5. doi: 10.1097/00000658-199206000-00016. Ann Surg. 1992. PMID: 1632689 Free PMC article.
-
Reresection for local recurrence of rectal cancer.Surg Today. 1999;29(10):999-1003. doi: 10.1007/s005950050635. Surg Today. 1999. PMID: 10554321
-
Is total pelvic exenteration reasonable primary treatment for rectal carcinoma?Ann Surg. 1988 Jun;207(6):670-8. doi: 10.1097/00000658-198806000-00005. Ann Surg. 1988. PMID: 3291792 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources